Skip to main content
Erschienen in: Operative Orthopädie und Traumatologie 6/2021

03.11.2021 | Surgical Techniques

Autologous matrix-induced chondrogenesis plus peripheral blood concentrate (AMIC+PBC) in chondral defects of the first metatarsophalangeal joint

verfasst von: Prof. Dr. Martinus Richter

Erschienen in: Operative Orthopädie und Traumatologie | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

Chondral restoration in chondral defects of the 1st metatarsophalangeal joint (MTP1) using autologous matrix-induced chondrogenesis plus peripheral blood concentrate (AMIC+PBC).

Indications

Chondral defects MTP1.

Contraindications

Acute infection.

Surgical technique

Thigh tourniquet. Medial approach. Tenolysis of all tendons, arthrolysis, synovectomy. Bursectomy in case of bursitis. Resection osteophytes, optional cheilectomy. Debridement of chondral defects until surrounding cartilage stable. Microfracturing with 1.6 mm K‑wire. 15 cc peripheral venous blood harvested with double lumina syringe. Centrifugation (10 min, 1500 RPM). Aspiration of supernatant including the entire fluid layer directly above the erythrocyte layer (peripheral blood concentrate [PBC]). Chondro-Gide matrix was cut to size and impregnated in PBC 3 min (impregnation). Fixation of the matrix into the chondral defect with fibrin glue (AMIC+PBC). Joint motion to ensure stable fixation. Insertion drainage and wound infiltration catheter. Layer wise closure.

Postoperative management

Full weightbearing in a dressing shoe. Joint motion exercise starting at the day of surgery.

Results

The aim of the study was to compare matrix-associated stem cell transplantation (MAST) with AMIC+PBC. Patients who were treated with MAST from October 1, 2011 to July 15, 2016 (n = 623) or with AMIC+PBC from July 17, 2016 to March 19, 2018 (n = 230) were included. In all, 480 (89%)/176 (89%) patients (MAST/AMIC+PBC) completed 2‑year follow-up. The average degree of osteoarthritis was 2.1/2.2. The chondral defect size was 0.9/1.0 cm2 on average. Visual Analogue Scale Foot and Ankle (VAS FA) and European Foot and Ankle Society score (EFAS score) improved to 72.4/74.1//16.8/17.1 (MAST//AMIC+PBC) at follow-up, respectively. No parameter significantly differed between the MAST and AMIC+PBC cohorts.
Literatur
1.
Zurück zum Zitat Benthien JP, Behrens P (2010) Autologous matrix-induced chondrogenesis (AMIC): combining Microfracturing and a collagen I/III matrix for articular cartilage resurfacing. Cartilage 1(1):65–68CrossRef Benthien JP, Behrens P (2010) Autologous matrix-induced chondrogenesis (AMIC): combining Microfracturing and a collagen I/III matrix for articular cartilage resurfacing. Cartilage 1(1):65–68CrossRef
2.
Zurück zum Zitat Dhurat R, Sukesh M (2014) Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. J Cutan Aesthet Surg 7(4):189–197CrossRef Dhurat R, Sukesh M (2014) Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. J Cutan Aesthet Surg 7(4):189–197CrossRef
3.
Zurück zum Zitat Giannini S, Buda R, Battaglia M, Cavallo M, Ruffilli A, Ramponi L, Pagliazzi G, Vannini F (2013) One-step repair in talar osteochondral lesions: 4‑year clinical results and t2-mapping capability in outcome prediction. Am J Sports Med 41(3):511–518CrossRef Giannini S, Buda R, Battaglia M, Cavallo M, Ruffilli A, Ramponi L, Pagliazzi G, Vannini F (2013) One-step repair in talar osteochondral lesions: 4‑year clinical results and t2-mapping capability in outcome prediction. Am J Sports Med 41(3):511–518CrossRef
4.
Zurück zum Zitat Giannini S, Buda R, Grigolo B, Bevoni R, Di Caprio F, Ruffilli A, Cavallo M, Desando G, Vannini F (2010) Bipolar fresh osteochondral allograft of the ankle. Foot Ankle Int 31(1):38–46CrossRef Giannini S, Buda R, Grigolo B, Bevoni R, Di Caprio F, Ruffilli A, Cavallo M, Desando G, Vannini F (2010) Bipolar fresh osteochondral allograft of the ankle. Foot Ankle Int 31(1):38–46CrossRef
5.
Zurück zum Zitat Giannini S, Buda R, Vannini F, Cavallo M, Grigolo B (2009) One-step bone marrow-derived cell transplantation in talar osteochondral lesions. Clin Orthop Relat Res 467(12):3307–3320CrossRef Giannini S, Buda R, Vannini F, Cavallo M, Grigolo B (2009) One-step bone marrow-derived cell transplantation in talar osteochondral lesions. Clin Orthop Relat Res 467(12):3307–3320CrossRef
6.
Zurück zum Zitat Giza E, Sullivan M, Ocel D, Lundeen G, Mitchell ME, Veris L, Walton J (2010) Matrix-induced autologous chondrocyte implantation of talus articular defects. Foot Ankle Int 31(9):747–753CrossRef Giza E, Sullivan M, Ocel D, Lundeen G, Mitchell ME, Veris L, Walton J (2010) Matrix-induced autologous chondrocyte implantation of talus articular defects. Foot Ankle Int 31(9):747–753CrossRef
7.
Zurück zum Zitat Gobbi A, Francisco RA, Lubowitz JH, Allegra F, Canata G (2006) Osteochondral lesions of the talus: randomized controlled trial comparing chondroplasty, microfracture, and osteochondral autograft transplantation. Arthroscopy 22(10):1085–1092CrossRef Gobbi A, Francisco RA, Lubowitz JH, Allegra F, Canata G (2006) Osteochondral lesions of the talus: randomized controlled trial comparing chondroplasty, microfracture, and osteochondral autograft transplantation. Arthroscopy 22(10):1085–1092CrossRef
8.
Zurück zum Zitat Hangody L, Fules P (2003) Autologous osteochondral mosaicplasty for the treatment of full-thickness defects of weight-bearing joints: ten years of experimental and clinical experience. J Bone Joint Surg Am 85-A(Suppl 2):25–32CrossRef Hangody L, Fules P (2003) Autologous osteochondral mosaicplasty for the treatment of full-thickness defects of weight-bearing joints: ten years of experimental and clinical experience. J Bone Joint Surg Am 85-A(Suppl 2):25–32CrossRef
9.
Zurück zum Zitat Mei-Dan O, Carmont MR, Laver L, Mann G, Maffulli N, Nyska M (2012) Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med 40(3):534–541CrossRef Mei-Dan O, Carmont MR, Laver L, Mann G, Maffulli N, Nyska M (2012) Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med 40(3):534–541CrossRef
10.
Zurück zum Zitat Niemeyer P, Salzmann G, Schmal H, Mayr H, Sudkamp NP (2011) Autologous chondrocyte implantation for the treatment of chondral and osteochondral defects of the talus: a meta-analysis of available evidence. Knee Surg Sports Traumatol Arthrosc 20(9):1696–1703CrossRef Niemeyer P, Salzmann G, Schmal H, Mayr H, Sudkamp NP (2011) Autologous chondrocyte implantation for the treatment of chondral and osteochondral defects of the talus: a meta-analysis of available evidence. Knee Surg Sports Traumatol Arthrosc 20(9):1696–1703CrossRef
11.
Zurück zum Zitat Richter M (2019) Mid-term (4–7 years) results of matrix-associated stem cell transplantation (MAST) in chondral defects of the first metatarsophalangeal joint. Fuss Sprungg 17:11–20CrossRef Richter M (2019) Mid-term (4–7 years) results of matrix-associated stem cell transplantation (MAST) in chondral defects of the first metatarsophalangeal joint. Fuss Sprungg 17:11–20CrossRef
12.
Zurück zum Zitat Richter M, Zech S (2008) 3D-imaging (ARCADIS) based computer assisted surgery (CAS) guided retrograde drilling in osteochondritis dissecans of the talus. Foot Ankle Int 29(12):1243–1248CrossRef Richter M, Zech S (2008) 3D-imaging (ARCADIS) based computer assisted surgery (CAS) guided retrograde drilling in osteochondritis dissecans of the talus. Foot Ankle Int 29(12):1243–1248CrossRef
13.
Zurück zum Zitat Richter M, Zech S (2013) Matrix-associated stem cell transplantation (MAST) in chondral defects of foot and ankle is effective. Foot Ankle Surg 19(2):84–90CrossRef Richter M, Zech S (2013) Matrix-associated stem cell transplantation (MAST) in chondral defects of foot and ankle is effective. Foot Ankle Surg 19(2):84–90CrossRef
14.
Zurück zum Zitat Richter M, Zech S, Meissner AS (2017) Matrix-associated stem cell transplantation (MAST) in chondral defects of the 1st metatarsophalangeal joint is safe and effective-2-year-follow-up in 20 patients. Foot Ankle Surg 23(3):195–200CrossRef Richter M, Zech S, Meissner AS (2017) Matrix-associated stem cell transplantation (MAST) in chondral defects of the 1st metatarsophalangeal joint is safe and effective-2-year-follow-up in 20 patients. Foot Ankle Surg 23(3):195–200CrossRef
15.
Zurück zum Zitat Richter M, Zech S, Meissner S, Naef I (2020) Comparison matrix-associated stem cell transplantation (MAST) with autologous matrix induced chondrogenesis plus peripheral blood concentrate (AMIC+PBC) in chondral lesions at the ankle—A clinical matched-patient analysis. Foot Ankle Surg 26(6):669–675CrossRef Richter M, Zech S, Meissner S, Naef I (2020) Comparison matrix-associated stem cell transplantation (MAST) with autologous matrix induced chondrogenesis plus peripheral blood concentrate (AMIC+PBC) in chondral lesions at the ankle—A clinical matched-patient analysis. Foot Ankle Surg 26(6):669–675CrossRef
16.
Zurück zum Zitat Richter M, Zech S, Meissner S, Naef I (2020) Matrix-associated stem cell transplantation (MAST) vs. autologous matrix induced chondrogenesis plus peripheral blood concentrate (AMIC+PBC) in Chondral defects of the first Metatarsophalangeal joint—a clinical cohort analysis. Fuss Sprungg 18:217–226CrossRef Richter M, Zech S, Meissner S, Naef I (2020) Matrix-associated stem cell transplantation (MAST) vs. autologous matrix induced chondrogenesis plus peripheral blood concentrate (AMIC+PBC) in Chondral defects of the first Metatarsophalangeal joint—a clinical cohort analysis. Fuss Sprungg 18:217–226CrossRef
17.
Zurück zum Zitat Shereff MJ, Baumhauer JF (1998) Hallux rigidus and osteoarthrosis of the first metatarsophalangeal joint. J Bone Joint Surg Am 80(6):898–908CrossRef Shereff MJ, Baumhauer JF (1998) Hallux rigidus and osteoarthrosis of the first metatarsophalangeal joint. J Bone Joint Surg Am 80(6):898–908CrossRef
18.
Zurück zum Zitat Smith PA (2016) Intra-articular autologous conditioned plasma injections provide safe and efficacious treatment for knee osteoarthritis: an FDA-sanctioned, randomized, double-blind, placebo-controlled clinical trial. Am J Sports Med 44(4):884–891CrossRef Smith PA (2016) Intra-articular autologous conditioned plasma injections provide safe and efficacious treatment for knee osteoarthritis: an FDA-sanctioned, randomized, double-blind, placebo-controlled clinical trial. Am J Sports Med 44(4):884–891CrossRef
19.
Zurück zum Zitat Tay LX, Ahmad RE, Dashtdar H, Tay KW, Masjuddin T, Ab-Rahim S, Chong PP, Selvaratnam L, Kamarul T (2012) Treatment outcomes of alginate-embedded allogenic mesenchymal stem cells versus autologous chondrocytes for the repair of focal articular cartilage defects in a rabbit model. Am J Sports Med 40(1):83–90CrossRef Tay LX, Ahmad RE, Dashtdar H, Tay KW, Masjuddin T, Ab-Rahim S, Chong PP, Selvaratnam L, Kamarul T (2012) Treatment outcomes of alginate-embedded allogenic mesenchymal stem cells versus autologous chondrocytes for the repair of focal articular cartilage defects in a rabbit model. Am J Sports Med 40(1):83–90CrossRef
20.
Zurück zum Zitat van Roermund PM, Marijnissen AC, Lafeber FP (2002) Joint distraction as an alternative for the treatment of osteoarthritis. Foot Ankle Clin 7(3):515–527CrossRef van Roermund PM, Marijnissen AC, Lafeber FP (2002) Joint distraction as an alternative for the treatment of osteoarthritis. Foot Ankle Clin 7(3):515–527CrossRef
Metadaten
Titel
Autologous matrix-induced chondrogenesis plus peripheral blood concentrate (AMIC+PBC) in chondral defects of the first metatarsophalangeal joint
verfasst von
Prof. Dr. Martinus Richter
Publikationsdatum
03.11.2021
Verlag
Springer Medizin
Erschienen in
Operative Orthopädie und Traumatologie / Ausgabe 6/2021
Print ISSN: 0934-6694
Elektronische ISSN: 1439-0981
DOI
https://doi.org/10.1007/s00064-021-00742-7

Weitere Artikel der Ausgabe 6/2021

Operative Orthopädie und Traumatologie 6/2021 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.